GLENVIEW CAPITAL MANAGEMENT, LLC Myriad Genetics, Inc. Transaction History

GLENVIEW CAPITAL MANAGEMENT, LLC portfolio value:

$27.88M
portfolio value

GLENVIEW CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+5.01%
quarter

Myriad Genetics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.87% -235.30K shares -2.94M $19.08 1.46M
Q2 2022 share Decrease -2.32% -40.21K shares -12.94M $18.17 1.69M
Q1 2022 share Increase +3.41% 57.26K shares -2.58M $25.2 1.73M
Q4 2021 share Decrease -24.85% -555.42K shares -25.81M $27.64 1.67M
Q3 2021 share Decrease -9.73% -240.91K shares -3.54M $32.29 2.23M
Q2 2021 share Decrease -3.63% -93.35K shares -2.52M $30.58 2.47M
Q1 2021 share Decrease -30.23% -1.11M shares 5.41M $30.45 2.56M
Q4 2020 share Increase +33.53% 924.69K shares 36.86M $19.78 3.68M
Q3 2020 share Increase +52.31% 947.26K shares 15.43M $13.04 2.75M
Q2 2020 share Increase +17.62% 271.19K shares -1.49M $11.34 1.81M
Q1 2020 share Decrease -55.31% -1.90M shares -71.77M $14.31 1.53M
Q4 2019 share Decrease -6.48% -238.51K shares -11.65M $27.23 3.44M
Q3 2019 share Increase 0.00% 3.68M shares 105.45M $28.63 3.68M